Riskpilot← Back to searchSign inGet full accessDocLand Invest AB
ABActiveOrg 5568076540Engelbrektsgatan 35Medical specialists activities · NACE 8622Est. 20101 employees
Revenue 2024
SEK 4,2M
0% vs 2023
EBITDA margin
69.9%
-8% vs 2023
Equity ratio
74.2%
Financial strength
Net profit 2024
SEK 2,9M
+41% vs 2023
| Revenue | SEK 4,2M | +0% |
| EBITDA | SEK 2,9M | -8% |
| Net profit | SEK 2,9M | +41% |
| Total assets | SEK 14,3M | +20% |
| Equity | SEK 10,6M | +38% |
| Employees | 1 | — |
Legal name
DocLand Invest AB
Org number
5568076540
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
5 maj 2010
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinsk verksamhet inom öron-näsa-hals och ögon området. Äga och förvalta fast egendom och värdepapper, bedriva vattenbruk samt därmed förenlig verksamhet.
Address
Engelbrektsgatan 35
Phone
+46703955795
Email
sundelin.staffan@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 075 | 3 720 | 3 107 | 4 188 | 4 168 |
| Staff expenses | — | — | — | — | −1 040 |
| EBITDA | 1 982 | −683 | 1 980 | 3 157 | 2 912 |
| Depreciation & amort. | −7 | −7 | −2 | −0 | — |
| EBIT | 1 975 | −690 | 1 978 | 3 157 | 2 912 |
| Net financials | −4 | −1 | — | 211 | 10 |
| Profit before tax | 1 637 | −684 | 1 490 | 2 567 | 3 721 |
| Tax | −357 | −529 | −311 | −500 | −797 |
| Net profit | 1 280 | −1 213 | 1 179 | 2 067 | 2 924 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 332 | 8 445 | 8 921 | 11 957 | 14 342 |
| Equity | 6 681 | 5 469 | 5 648 | 7 715 | 10 640 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 742 | 1 074 | 883 | 1 052 | 1 312 |
| Total debt | 742 | 1 074 | 883 | 1 052 | 1 312 |
EBITDA margin
69.9%
This company
15.8%
Market median
+342% vs market
20202024
Equity ratio
74.2%
This company
38.2%
Market median
+94% vs market
20202024
Return on equity
27.5%
This company
18.4%
Market median
+49% vs market
20202024
Net profit margin
70.2%
This company
8.1%
Market median
+767% vs market
20202024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20202024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BE | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DocLand Invest AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Erik Lennart Ellison | Audit | 0 companies |
| Anna Eeva Rosa Sundelin | Deputy Board Member | 0 companies |
| Pär Staffan Sundelin | Board of Directors | 0 companies |
| Jesper Pär Nikolai Sundelin | Deputy Board Member | 0 companies |